Influences on the prescribing of new drugs

BACKGROUND: The aim of this study was to identify the factors that influence prescribing of new drugs among general practitioners, endocrinologists and psychiatrists. METHODS: Four focus groups were conducted with GPs, endocrinologists and psychiatrists on sources of awareness and influences on pres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Australian family physician 2008-01, Vol.37 (1-2), p.78-83
Hauptverfasser: Tobin, Luke, de Almedia Neto, Abelio C, Wutzke, Sonia, Patterson, Craig, Mackson, Judith, Weekes, Lynn, Williamson, Margaret
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND: The aim of this study was to identify the factors that influence prescribing of new drugs among general practitioners, endocrinologists and psychiatrists. METHODS: Four focus groups were conducted with GPs, endocrinologists and psychiatrists on sources of awareness and influences on prescribing of new drugs. RESULTS: Pharmaceutical companies were the most important source for becoming aware of new drugs. There were many influences on the decision to prescribe a new drug, the most important being efficacy, safety, cost and advantage over existing therapies. Endocrinologists placed greater emphasis on evidence from clinical trials and scientific conferences, and psychiatrists and GPs placed more weight on pharmaceutical representatives, colleagues and specialists. DISCUSSION: New drug prescribing occurs in a complex environment with many influences. Effective interventions to promote rational, safe and effective prescribing of new drugs will need to be cognisant of these factors. (author abstract)
ISSN:0300-8495
2208-7958